NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $290 | -99.9% | 2,842 | +1.5% | 0.07% | +16.1% |
| Q2 2023 | $250,386 | -41.2% | 2,800 | -41.4% | 0.06% | -29.5% |
| Q1 2023 | $425,956 | +65.1% | 4,780 | +51.9% | 0.09% | -4.3% |
| Q3 2021 | $258,000 | +13.7% | 3,147 | +26.6% | 0.09% | +4.5% |
| Q2 2021 | $227,000 | +7.1% | 2,486 | +4.9% | 0.09% | -15.4% |
| Q1 2021 | $212,000 | 0.0% | 2,371 | 0.0% | 0.10% | 0.0% |
| Q4 2020 | $212,000 | +7.1% | 2,371 | +4.0% | 0.10% | -11.1% |
| Q3 2020 | $198,000 | +29.4% | 2,280 | +30.2% | 0.12% | +8.3% |
| Q2 2020 | $153,000 | +13.3% | 1,751 | +6.8% | 0.11% | -8.5% |
| Q1 2020 | $135,000 | -63.4% | 1,640 | -57.9% | 0.12% | -59.5% |
| Q4 2019 | $369,000 | +10.5% | 3,897 | +1.3% | 0.29% | -7.9% |
| Q3 2019 | $334,000 | -10.0% | 3,847 | -5.3% | 0.32% | -2.8% |
| Q2 2019 | $371,000 | +11.7% | 4,063 | +17.5% | 0.32% | +30.0% |
| Q1 2019 | $332,000 | +207.4% | 3,458 | +174.7% | 0.25% | +208.6% |
| Q4 2018 | $108,000 | – | 1,259 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |